Report LibraryAll Reports
Datamonitor Healthcare Oncology: Head and Neck Cancer Disease Coverage
Retail Price: $22,000.00*BioMedTracker Subscriber Price: $15,000.00 - click here to log in
December 01, 2017Head and neck cancer is the sixth most common cancer worldwide, and includes malignancies that can originate in the oral cavity, salivary glands, sinuses, and throat. Around 90% of cases have an epithelial origin, which present as squamous cell carcinomas. Environmental factors such as tobacco smoking and alcohol consumption greatly increase the risk of developing head and neck cancers. If diagnosed at an early stage, treatment for these cancers can be curative; however, the majority of patients are diagnosed when the disease is advanced, resulting in the need for more than one treatment modality.
This Datamonitor Healthcare Disease Coverage report contains Forecast, Treatment, Epidemiology, Marketed Drugs, and Pipeline modules.
|Disease Group Covered:||Oncology|